Perioperative antihypertensive medication use is associated with no antifibrotic benefit but higher complications and revision rates following shoulder arthroplasty.
Saved in:
| Title: | Perioperative antihypertensive medication use is associated with no antifibrotic benefit but higher complications and revision rates following shoulder arthroplasty. |
|---|---|
| Authors: | Parmar T; Division of Shoulder and Elbow Surgery, Rothman Orthopaedics, Philadelphia, USA. txp539@students.jefferson.edu., Fiandeiro M; Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Daher M; Division of Shoulder and Elbow Surgery, Rothman Orthopaedics, Philadelphia, USA., Adio A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Lawand J; John Sealy School of Medicine, The University of Texas Medical Branch at Galveston, Galveston, USA., Khan A; Department of Orthopedic Surgery, Southern California Permanente Medical Group, Panorama City, USA., Abboud J; Division of Shoulder and Elbow Surgery, Rothman Orthopaedics, Philadelphia, USA. |
| Source: | European journal of orthopaedic surgery & traumatology : orthopedie traumatologie [Eur J Orthop Surg Traumatol] 2026 Aug 01; Vol. 36 (1). Date of Electronic Publication: 2026 Aug 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 9518037 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1068 (Electronic) Linking ISSN: 16338065 NLM ISO Abbreviation: Eur J Orthop Surg Traumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
